NGR1 enhances p-Akt levels in hiPSC-CMs and, when used as a pretreatment, improves the therapeutic efficacy of hiPSC-CM transplantation in MI by promoting graft survival and activating paracrine repair mechanisms. This evidence concerns the gene AKT1 and myocardial infarction.